Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

27.67
+0.99003.71%
Post-market: 28.180.5100+1.84%18:49 EDT
Volume:5.03M
Turnover:138.63M
Market Cap:4.42B
PE:-67.27
High:28.72
Open:27.09
Low:27.03
Close:26.68
52wk High:28.72
52wk Low:12.00
Shares:159.76M
Float Shares:125.00M
Volume Ratio:2.71
T/O Rate:4.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4113
EPS(LYR):-0.3922
ROE:-38.76%
ROA:-4.12%
PB:30.93
PE(LYR):-70.56

Loading ...

Adaptive Biotechnologies Issues $345 Million Convertible Notes

MT Newswires Live
·
Jun 23

Adaptive Biotechnologies Corp - Issues $345 Mln in 0% Convertible Senior Notes Due 2031 - SEC Filing

THOMSON REUTERS
·
Jun 23

Adaptive Biotechnologies prices upsized USD 300 million 0% convertible senior notes offering due 2031

Reuters
·
Jun 23

Adaptive Biotechnologies CSO Harlan S. Robins sells 106,160 shares for $1.85 million

Reuters
·
Jun 18

BUZZ-U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron

Reuters
·
Jun 17

Adaptive Biotechnologies Price Target Maintained With a $22.00/Share by BTIG

Dow Jones
·
Jun 17

Adaptive Biotechnologies prices $300M convertible senior note offering

TIPRANKS
·
Jun 17

BUZZ-U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile

Reuters
·
Jun 17

BUZZ-Adaptive Biotechnologies up after boosted $300 mln convertible bond sale

Reuters
·
Jun 17

Adaptive Biotechnologies prices upsized USD 300 million 0% convertible senior notes offering due 2031

Reuters
·
Jun 17

Adaptive Biotechnologies - Prices $300 Mln 0% Convertible Senior Notes Due 2031

THOMSON REUTERS
·
Jun 17

Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering

GlobeNewswire
·
Jun 17

MRD Spinoff And $250 Million Convertible Notes Could Be A Game Changer For Adaptive Biotechnologies (ADPT)

Simply Wall St.
·
Jun 17

Analysts Are Bullish on Top Healthcare Stocks: Pasithea Therapeutics Corp (KTTA), Adaptive Biotechnologies (ADPT)

TIPRANKS
·
Jun 16

Adaptive Biotechnologies offers to sell $250M in 2031 convertible senior notes

TIPRANKS
·
Jun 16

Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 common shares for $95,000

Reuters
·
Jun 16

Stocks to Watch: Dave & Buster's, Adaptive Biotechnologies, Domo, Apollo Commercial Real Estate Finance

Dow Jones
·
Jun 16

BRIEF-Adaptive Biotechnologies Announces Proposed Convertible Senior Notes Offering

Reuters
·
Jun 16

Adaptive Biotechnologies Evaluates Strategic Alternatives for Immune Medicine Business

Dow Jones
·
Jun 16

Adaptive Biotechnologies Weighs Separation of Immune Medicine Unit; Shares Fall After Hours

MT Newswires Live
·
Jun 16